アボネックスの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

アボネックス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6%で24億3,920万米ドルに成長します。予測期間の成長は、多発性硬化症（MS）有病率の上昇、経口薬への嗜好の高まり、患者支援への期待の高まり、有効性を裏付ける臨床エビデンスの増加、注射剤代替品の市場シェア拡大などに起因すると考えられます。予測期間における主要動向には、先進的データ分析、生物学的指標に対する需要、3Dバイオプリンティングの利用、免疫調節技術の統合、ナノテクノロジーの利用などがあります。

多発性硬化症（MS）の有病率の増加がアボネックス市場の成長を牽引すると予想されます。MSは慢性の自己免疫疾患であり、免疫系が中枢神経系の神経線維を取り囲む保護ミエリン鞘を攻撃し、脳と身体のコミュニケーションに障害を引き起こします。MS症例の増加は、診断能力の向上、ビタミンD欠乏症などの環境要因、遺伝的素因、ライフスタイルや移動パターンの変化などに起因しています。アボネックスは、炎症を抑え、再発頻度を減少させ、免疫系の調節を通じて身体障害の進行を遅らせることにより、MSを管理する上で極めて重要です。例えば、多発性硬化症トラストが2024年5月に発表した報告書によると、英国におけるMS患者数は約13％増加し、イングランドで15％、スコットランドで10％、北アイルランドで9％、ウェールズで8％増加しています。このような有病率の増加は、MSの管理におけるアボネックスに対する需要の高まりを強調し、市場の成長を後押ししています。

アボネックス市場の主要動向は、治療オプション、患者の転帰、慢性疾患管理の強化を目的とした戦略的パートナーシップの開拓です。戦略的パートナーシップにより、組織は強み、リソース、専門知識を組み合わせて相互の目標を達成し、競争上の優位性を高めることができます。例えば、2022年6月、アボネックス（インターフェロンβ1a）の米国メーカーであるBiogen Inc.は、Happify Healthと協業し、AIを活用したデジタルソリューションを開発しました。このプラットフォームは、MSとともに生きる個人のための患者教育とエンゲージメントを強化するもので、治療管理、専門家による相談へのアクセス、治療オプションの検討のためのツールを提供するとともに、支援コミュニティを育成します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のアボネックス：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアボネックス市場：成長率分析
• 世界のアボネックス市場の実績：規模と成長、2019～2024年
• 世界のアボネックス市場の予測：規模と成長、2024～2029年、2034年
• 世界のアボネックス：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のアボネックス市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プレフィルドシリンジ
• 粉末
• 世界のアボネックス市場：疾患別、実績と予測、2019～2024年、2024～2029年、2034年
• 再発性多発性硬化症（RMS）
• 臨床的孤立症候群（CIS）
• 多発性硬化症の再発率の低下
• 障害の進行遅延
• 多発性硬化症における長期疾患管理
• 早期MS治療
• 世界のアボネックス市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 卸売業者
• 小売薬局
• 患者直接販売（DTP）
• 世界のアボネックス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ドラッグストア
• その他

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のアボネックス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のアボネックス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• アボネックス市場：競合情勢
• アボネックス市場：企業プロファイル
  • Biogen Inc

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• アボネックス市場、2029年：新たな機会を提供する国
• アボネックス市場、2029年：新たな機会を提供するセグメント
• アボネックス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Avonex, a brand of interferon beta-1a, is primarily used to treat relapsing forms of multiple sclerosis (MS). It is effective in reducing relapse frequency and slowing the progression of physical disability associated with MS. As an immunomodulator, Avonex works by modifying the immune system's activity, reducing inflammation, and limiting nervous system damage caused by the disease.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of avonex are prefilled syringes and powder forms. Prefilled syringes are single-dose containers that come ready for injection, pre-filled with the medication and equipped with a needle, offering convenience for various medical treatments. The clinical indications for Avonex include relapsing forms of multiple sclerosis (RMS), clinically isolated syndrome (CIS), relapse rate reduction in MS, slowing disability progression, long-term disease management in MS, and early-stage MS treatment. It is distributed through multiple channels such as wholesalers, retail pharmacies, and direct-to-patient (DTP) sales, and is used in settings like hospitals, drug stores, and others.

The avonex market research report is one of a series of new reports from The Business Research Company that provides avonex market statistics, including avonex industry global market size, regional shares, competitors with a avonex market share, detailed avonex market segments, market trends and opportunities, and any further data you may need to thrive in the avonex industry. This avonex market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The avonex market size is expected to see strong growth in the next few years. It will grow to $2,439.2 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rise in multiple sclerosis (MS) prevalence, increasing preference for oral medications, rising patient support expectations, increasing clinical evidence supporting efficacy, increasing market share of injectable alternatives. Major trends in the forecast period include advanced data analytics, demand for biological indicators, utilization of 3D bioprinting, integration of immunomodulatory technology, use of nanotechnology.

The increasing prevalence of multiple sclerosis (MS) is expected to drive the growth of the avonex market. MS is a chronic autoimmune disease where the immune system attacks the protective myelin sheath surrounding nerve fibers in the central nervous system, causing disruptions in brain-body communication. The rise in MS cases can be attributed to improved diagnostic capabilities, environmental factors such as vitamin D deficiency, genetic predisposition, and changes in lifestyle and migration patterns. Avonex is critical in managing MS by reducing inflammation, decreasing relapse frequency, and slowing physical disability progression through immune system modulation. For example, a report published by the Multiple Sclerosis Trust in May 2024 revealed a nearly 13% increase in the number of people living with MS in the UK, with a 15% rise in England, 10% in Scotland, 9% in Northern Ireland, and 8% in Wales. This growing prevalence underscores the rising demand for avonex in managing MS, fueling market growth.

A key trend in the avonex market is the development of strategic partnerships aimed at enhancing treatment options, patient outcomes, and chronic disease management. Strategic partnerships allow organizations to combine strengths, resources, and expertise to achieve mutual goals and improve competitive advantage. For instance, in June 2022, Biogen Inc., the US-based manufacturer of Avonex (interferon beta-1a), collaborated with Happify Health to create an AI-powered digital solution. This platform enhances patient education and engagement for individuals living with MS, offering tools to manage care, access expert consultations, and explore treatment options while fostering a supportive community.

In November 2024, Vanguard Group Inc., a US-based investment firm, acquired shares in Biogen Inc. for an undisclosed amount. This acquisition reflects Vanguard's strategy to diversify its investment portfolio and support companies with strong growth potential and innovative product pipelines, further strengthening Biogen's position in the Avonex market.

Key player operating in the avonex market is Biogen Inc

North America was the largest region in the avonex market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in avonex report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the avonex market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The avonex market consists of sales of monoclonal antibodies, spinal muscular atrophy medications, biosimilars and immunomodulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Avonex Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on avonex market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for avonex ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The avonex market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prefilled Syringe; Powder Form
• 2) Clinical Indication: Relapsing Forms Of Multiple Sclerosis (RMS); Clinically Isolated Syndrome (CIS); Relapse Rate Reduction In MS; Slowing Disability Progression; Long-term Disease Management In MS; Early-Stage MS Treatment
• 2) By Distribution Channel: Wholesalers; Retail Pharmacies; Direct-To-Patient (Dtp) Sales
• 3) By Application: Hospital; Drugs Store; Other Applications
• Companies Mentioned: Biogen Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Avonex Market Characteristics

3. Avonex Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Avonex Market Trends And Strategies

5. Avonex Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Avonex Growth Analysis And Strategic Analysis Framework

• 6.1. Global Avonex PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Avonex Market Growth Rate Analysis
• 6.4. Global Avonex Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Avonex Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Avonex Total Addressable Market (TAM)

7. Global Avonex Market Pricing Analysis & Forecasts

8. Avonex Market Segmentation

• 8.1. Global Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prefilled Syringe
• Powder Form
• 8.2. Global Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Relapsing Forms Of Multiple Sclerosis (RMS)
• Clinically Isolated Syndrome (CIS)
• Relapse Rate Reduction In MS
• Slowing Disability Progression
• Long-term Disease Management in MS
• Early-Stage MS Treatment
• 8.3. Global Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wholesalers
• Retail Pharmacies
• Direct-To-Patient (Dtp) Sales
• 8.4. Global Avonex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Drug Stores
• Other Applications

9. Global Avonex Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Avonex Market Regional And Country Analysis

• 10.1. Global Avonex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Avonex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Avonex Market

• 11.1. Asia-Pacific Avonex Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Avonex Market

• 12.1. China Avonex Market Overview
• 12.2. China Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Avonex Market

• 13.1. India Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Avonex Market

• 14.1. Japan Avonex Market Overview
• 14.2. Japan Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Avonex Market

• 15.1. Australia Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Avonex Market

• 16.1. South Korea Avonex Market Overview
• 16.2. South Korea Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Avonex Market

• 17.1. Western Europe Avonex Market Overview
• 17.2. Western Europe Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Avonex Market

• 18.1. UK Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Avonex Market

• 19.1. Germany Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Avonex Market

• 20.1. France Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Avonex Market

• 21.1. Eastern Europe Avonex Market Overview
• 21.2. Eastern Europe Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Avonex Market

• 22.1. North America Avonex Market Overview
• 22.2. North America Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Avonex Market

• 23.1. USA Avonex Market Overview
• 23.2. USA Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Avonex Market

• 24.1. Canada Avonex Market Overview
• 24.2. Canada Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Avonex Market

• 25.1. South America Avonex Market Overview
• 25.2. South America Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Avonex Market

• 26.1. Middle East Avonex Market Overview
• 26.2. Middle East Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Avonex Market

• 27.1. Africa Avonex Market Overview
• 27.2. Africa Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Avonex Market Competitive Landscape And Company Profiles

• 28.1. Avonex Market Competitive Landscape
• 28.2. Avonex Market Company Profiles
  • 28.2.1. Biogen Inc Overview, Products and Services, Strategy and Financial Analysis

29. Global Avonex Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Avonex Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Avonex Market

32. Recent Developments In The Avonex Market

33. Avonex Market High Potential Countries, Segments and Strategies

• 33.1 Avonex Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Avonex Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Avonex Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer